captopril has been researched along with carvedilol in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 16 (69.57) | 29.6817 |
| 2010's | 5 (21.74) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brooks, DP; Contino, LC; Cyronak, MJ; DiCristo, M; Ruffolo, RR; Short, BG; Wang, YX | 1 |
| Hauf-Zachariou, U; Hennig, M; Lang, PD; Widmann, L; Zülsdorf, B | 1 |
| Khattar, RS; Lahiri, A; Senior, R; Soman, P; van der Does, R | 1 |
| Doing, AH; Renlund, DG; Smith, RA | 1 |
| Dimitrijevic, J; Djukanovic, L; Jovanovic, D; Jovovic, D; Maksic, N; Mihailovic-Stanojevic, N; Miloradovic, Z | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Juranic, Z; Mihailovic-Stanojevic, N; Petrovic, T; Stanojkovic, TP; Zizak, Z | 1 |
| Dzhaiani, NA; Morozova, MN; Tereshchenko, SN | 1 |
| Bacal, F; Bocchi, EA; Chizzola, PR; Guimarães, GV; Issa, VS; Mangini, S; Moreira, SF; Pires, PV; Silva, CP; Souza, GE | 1 |
| Catena, C; Donnini, D; Milocco, C; Moretti, M; Sechi, LA; Soardo, G | 1 |
| Asif, H; Chaudhari, MP; Crossland, DS; Kirk, RC; O'Sullivan, JJ; Roche, SL | 1 |
| Dimitrijevic, J; Djukanovic, L; Jovanovic, D; Jovovic, D; Maksic, N; Mihailovic-Stanojevic, N; Miloradovic, Z; Naumovic, R | 1 |
| Bocchi, EA; Carvalho, VO; Guimarães, GV | 1 |
1 review(s) available for captopril and carvedilol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for captopril and carvedilol
| Article | Year |
|---|---|
A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.
Topics: Adult; Aged; Antihypertensive Agents; Captopril; Carbazoles; Carvedilol; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Female; Humans; Hyperlipoproteinemias; Hypertension; Lipoproteins; Male; Middle Aged; Propanolamines; Triglycerides | 1993 |
Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Cardiac Catheterization; Carvedilol; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Stroke Volume; Treatment Outcome; Ventricular Remodeling | 2001 |
[Comparative efficacy of carvedilol and capoten in the treatment of an uncomplicated hypertensive crisis].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Carbazoles; Carvedilol; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Propanolamines; Treatment Outcome | 2006 |
19 other study(ies) available for captopril and carvedilol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Blood Urea Nitrogen; Captopril; Carbazoles; Carvedilol; Creatinine; Glomerulosclerosis, Focal Segmental; Heart Rate; Hypertension; Kidney; Kidney Failure, Chronic; Male; Propanolamines; Proteinuria; Rats; Rats, Sprague-Dawley | 1993 |
Becker muscular dystrophy-related cardiomyopathy: a favorable response to medical therapy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Carbazoles; Cardiomyopathies; Carvedilol; Heart Failure; Humans; Male; Muscular Dystrophy, Duchenne; Propanolamines; Stroke Volume; Treatment Outcome | 2002 |
Influence of carvedilol on chronic renal failure progression in spontaneously hypertensive rats with adriamycin nephropathy.
Topics: Animals; Antibiotics, Antineoplastic; Antihypertensive Agents; Blood Pressure; Captopril; Carbazoles; Carvedilol; Disease Models, Animal; Disease Progression; Doxorubicin; Drug Therapy, Combination; Female; Kidney Failure, Chronic; Nephritis; Propanolamines; Rats; Rats, Inbred SHR | 2005 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
Inhibition of proliferation on some neoplastic cell lines-act of carvedilol and captopril.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Carvedilol; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Microscopy, Fluorescence; Propanolamines | 2005 |
Heart failure treatment profile at the beta blockers era.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Propanolamines; Severity of Illness Index | 2007 |
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells.
Topics: Antihypertensive Agents; Captopril; Carbazoles; Carvedilol; Cells, Cultured; Dihydropyridines; Dose-Response Relationship, Drug; Endothelial Cells; Ethanol; Humans; Malondialdehyde; Nitric Oxide; Oxidative Stress; Propanolamines | 2008 |
Recovery of heart function in children with acute severe heart failure.
Topics: Acute Disease; Captopril; Carbazoles; Cardiotonic Agents; Carvedilol; Child; Child, Preschool; Databases, Factual; Digoxin; Enalapril; Enoximone; Female; Heart Failure; Heart Function Tests; Humans; Infant; Infant, Newborn; Male; Propanolamines; Treatment Outcome | 2008 |
Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Captopril; Carbazoles; Carvedilol; Creatinine; Disease Models, Animal; Disease Progression; Doxorubicin; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Kidney Failure, Chronic; Propanolamines; Proteinuria; Rats; Rats, Inbred SHR; Time Factors | 2009 |
The relationship between heart rate reserve and oxygen uptake reserve in heart failure patients on optimized and non-optimized beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Losartan; Male; Middle Aged; Oxygen Consumption; Propanolamines | 2008 |